Dolby Laboratories (NYSE:DLB).
Raymond James & Associates raised its ownership in Dolby Laboratories stock by 5.0% in a 13F filing with the SEC. Its position was worth $16,824,000 an increase of 23.3% according to the filing.
Here are some institutional investors who have increased or decreased their stake in (DLB). As of quarter end Timucuan Asset Management Inc/fl had bought a total of 41,043 shares growing its position 3.5%. The value of the investment in (DLB) increased from $57,394,000 to $69,790,000 a change of 21.6% since the last quarter. Raymond James & Associates bolstered its position by buying 13,825 shares an increase of 5.0%. Raymond James & Associates now holds 292,493 shares worth $16,824,000. The total value of its holdings increased 23.3%.
Raymond James & Associates expanded its stake by buying 13,825 shares an increase of 5.0% from 06/30/2017 to 09/30/2017. Raymond James & Associates claims 292,493 shares with a value of $16,824,000. The value of the position overall is up by 23.3%. As of the end of the quarter Alliancebernstein L.P. had acquired 326,071 shares growing its holdings by 35.9%. The value of the investment in DLB went from $44,455,000 to $70,983,000 a change of $26,528,000 quarter to quarter.
Baird Financial Group, Inc. augmented its ownership by buying 42,174 shares an increase of 107.6% as of 09/30/2017. Baird Financial Group, Inc. currently owns 81,355 shares valued at $4,680,000. The total value of its holdings increased 144.0%.
October 26 investment analysts at B. Riley maintained a stock rating of “Buy” with a current price target of $65.50. Equity analyst B. Riley released research on DLB with a rating of “Buy” and a price target of $66.00.
On September 14 B. Riley kept the company rating at “Buy” projecting a price of $61.50. September 13 investment analysts at Piper Jaffray Companies made no change to the stock rating of “Hold” targeting a price of $52.00.
September 13 investment analysts at Dougherty & Co left the stock rating at “Buy” projecting a price of $63.00. On August 18, 2017 B. Riley updated guidance on DLB and giving a rating of “Buy” and establishing a price target of $62.00.
In the market the company is trading up since yesterday’s close of 61. The company’s P/E ratio is 31.44 and the market value is 6.23B. As of the last earnings report the EPS was $1.94 with 57.89M shares presently outstanding.
Investors are feeling more bullish on Dolby Laboratories lately at least if you consider the decrease in short interest. The company had a fall in short interest of -11.75% as of October 31, 2017 from the last reporting period. Short shares fell 192,805 over that period. Days to cover decreased -4.0 to 3.0 and the percentage of shorted shares is 0.03% as of October 31.